# Effect of Probiotics on Gut-Liver Axis of Alcoholic Hepatitis

> **NCT02335632** · PHASE4 · UNKNOWN · sponsor: **Chuncheon Sacred Heart Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Alcoholic Liver Disease

## Interventions

- **DRUG:** Probiotics (Lacidofil®)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02335632
- **Lead sponsor:** Chuncheon Sacred Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2015-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02335632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02335632, "Effect of Probiotics on Gut-Liver Axis of Alcoholic Hepatitis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02335632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
